Literature DB >> 922497

Regional differences in the sensitivity of cholinergic neurons to dopaminergic drugs and quipazine in the rat striatum.

P Guyenet, C Euvrard, F Javoy, A Herbert, J Glowinski.   

Abstract

Marked differences were found in the activity of choline acetylase (ChAc) in various discrete areas of the rat striatum. The richest cholinergic innervation was observed in the centrolateral part of the structure. A similar distribution was obtained by measuring acetycholine (ACh) levels in punches taken from frozen frontal serial slices. As revealed by the analysis of the topographical distributions of ChAc activity, ACh, 5-HT and DA, the regional cholinergic innervation differed markedly from that of aminergic terminals. Changes in ACh levels induced by drugs could be estimated in microdiscs of tissues punched from frozen slices. Apomorphine and haloperidol, which increased and decreased ACh levels respectively, induced similar effects in the various striatal areas examined. By contrast quipazine, a drug acting on 5-HT uptake and release and on serotoninergic receptors, selectively increased ACh levels in some areas of the striatum but not in others. The regional changes in ACh levels induced by quipazine were satisfactorily correlated with the regional distribution of 5-HT but not with that of DA. These results suggest that a limited population of striatal cholinergic neurons is under the inhibitory control of serotoninergic neurons. They also indicate that some striatal cholinergic neurons influenced by dopaminergic neurons are not controlled by serotoninergic neurons.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 922497     DOI: 10.1016/0006-8993(77)90073-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Recombinant human nerve growth factor is biologically active and labels novel high-affinity binding sites in rat brain.

Authors:  C A Altar; L E Burton; G L Bennett; M Dugich-Djordjevic
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

2.  Minaprine improves impairment of working memory induced by scopolamine and cerebral ischemia in rats.

Authors:  T Yamamoto; S Yatsugi; M Ohno; Y Furuya; I Kitajima; S Ueki
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Neurochemical effects of minaprine, a novel psychotropic drug, on the central cholinergic system of the rat.

Authors:  S Garattini; G L Forloni; S Tirelli; H Ladinsky; S Consolo
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183).

Authors:  M R Marien; S M Parsons; C A Altar
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.

Authors:  S L Dewey; G S Smith; J Logan; J D Brodie; P Simkowitz; R R MacGregor; J S Fowler; N D Volkow; A P Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.